SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML

被引：5
|
作者：
Sutherland, May S. K. [1 ]
Walter, Roland B. [2 ]
Jeffrey, Scott C. [1 ]
Burke, Patrick J. [1 ]
Yu, Changpu [1 ]
Harrington, Kimberly H. [2 ]
Stone, Ivan [1 ]
Ryan, Maureen C. [1 ]
Sussman, Django [1 ]
Zeng, Weiping [1 ]
Benjamin, Dennis R. [1 ]
Bernstein, Irwin D. [2 ]
Senter, Peter D. [1 ]
Drachman, Jonathan G. [1 ]
McEarchern, Julie A. [1 ]
机构：
[1] Seattle Genet Inc, Res & Translat Med, Bothell, WA USA
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3589.3589
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3589
引用
收藏
页数：2
相关论文
共 45 条
  • [21] Combining IMGN779, a Novel Anti-CD33 Antibody-Drug Conjugate (ADC), with the PARP Inhibitor, Olaparib, Results in Enhanced Anti-Tumor Activity in Preclinical Acute Myeloid Leukemia (AML) Models
    Portwood, Scott
    Puchalski, Robert A.
    Walker, Russell M.
    Wang, Eunice S.
    BLOOD, 2016, 128 (22)
  • [22] Combination of the anti-CD30-auristatin-E antibody-drug conjugate SGN-35 with chemotherapy improves antitumor activity in Hodgkin's lymphoma
    Oflazoglu, E.
    Kennedy, D.
    Sievers, E. L.
    Kissler, K. M.
    Jonas, M.
    Ihle, N. C.
    Grewal, I. S.
    Gerber, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 235 - 236
  • [23] Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML
    Laszlo, George S.
    Gudgeon, Chelsea J.
    Harrington, Kimberly H.
    Dell'Aringa, Justine
    Newhall, Kathryn J.
    Means, Gary D.
    Sinclair, Angus M.
    Kischel, Roman
    Frankel, Stanley R.
    Walter, Roland B.
    BLOOD, 2014, 123 (04) : 554 - 561
  • [24] Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models
    Whiteman, Kathleen R.
    Johnson, Holly A.
    Mayo, Michele F.
    Audette, Charlene A.
    Carrigan, Christina N.
    LaBelle, Alyssa
    Zukerberg, Lawrence
    Lambert, John M.
    Lutz, Robert J.
    MABS, 2014, 6 (02) : 556 - 566
  • [25] IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate (ADC) Demonstrates Initial Antileukemia Activity in Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Cortes, Jorge E.
    Traer, Elie
    Wang, Eunice S.
    Erba, Harry P.
    Blum, William
    Arana-Yi, Cecilia
    Sloss, Callum M.
    Culm-Merdek, Kerry
    Towles, Jeanette
    Zweidler-McKay, Patrick A.
    DeAngelo, Daniel J.
    BLOOD, 2017, 130
  • [26] Potent antitumor activity of the anti-CD19 auristatin antibody-drug conjugate hBU12-vcMMAE in rituximab sensitive and resistant lymphomas
    Gerber, H. P.
    Stone, I.
    Kung-Sutherland, M.
    Miyamoto, J.
    Okeley, N.
    Alley, S. C.
    Meyer, D. L.
    Sussman, D.
    Senter, P.
    Grewal, I. S.
    EJC SUPPLEMENTS, 2008, 6 (12): : 161 - 161
  • [27] Treatment of patients with relapsed or refractory acute myeloid leukemia (AML) with recombinant engineered human anti-CD33 antibody-calicheamicin drug conjugate
    Sievers, EL
    Bernstein, ID
    Spielberger, RT
    Forman, SJ
    ShannonDorcy, K
    Appelbaum, FR
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 398 - 398
  • [28] DS-6000a, a novel CDH6-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
    Suzuki, H.
    Nagase, S.
    Saito, C.
    Nagata, M.
    Kaneda, Y.
    Honda, K.
    Nishiya, Y.
    Honda, T.
    Nakada, T.
    Goto, R.
    Ishizaka, T.
    Myobatake, Y.
    Abe, Y.
    Agatsuma, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S363 - S364
  • [29] DS-1062a, a novel TROP2-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
    Okajima, Daisuke
    Yamaguchi, Junko
    Kitamura, Michiko
    Kamei, Reiko
    Maejima, Takanori
    Shibutani, Tomoko
    Yasuda, Satoru
    Toki, Tadashi
    Karibe, Tsuyoshi
    Fujitani, Tomomichi
    Nakada, Takashi
    Goto, Riki
    Noguchi, Yutaka
    Abe, Yuki
    Agatsuma, Toshinori
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [30] ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors
    Lopez, Marc
    Crompot, Emerence
    Josselin, Emmanuelle
    Farina, Anne
    Rubis, Marion
    Castellano, Remy
    Fares, Joanna
    Wehbe, Maria
    Collette, Yves
    Charafe, Emmanuelle
    Blanchin, Stephanie
    Romagne, Francois
    Palfi, Aniko
    Hechler, Torsten
    Pahl, Andreas
    Azim Jr, Hatem A.
    Lhospice, Florence
    Mamessier, Emilie
    Bertucci, Francois
    Elands, Jack
    Preville, Xavier
    Olive, Daniel
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (11): : 2998 - 3012
12345